Century Therapeutics

This biotechnology company is known for its innovative approach in building an industry-leading platform for allogeneic iPSC-derived cell therapy. The platform integrates advanced gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies. The company's work is at the forefront of the biotech industry, pushing the boundaries of what's possible in cell therapy.